Back to Archived Journals » Biosimilars » Volume 4 » default
Biosimilars ceased publishing in October 2016. All new submissions can be made to Biologics: Targets and Therapy. All articles that have been published in Biosimilars will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Biosimilars
ISSN: 2230-245X
- View all (31)
- Volume 6, 2016 (6)
- Volume 5, 2015 (9)
- Volume 4, 2014 (4)
- Volume 3, 2013 (6)
- Volume 2, 2012 (4)
- Volume 1, 2011 (2)
Archive: Volume 4, 2014
Production and manufacturing of biosimilar insulins: implications for patients, physicians, and health care systems
Kuhlmann MK, Schmidt A
Biosimilars 2014, 4:45-58
Published Date: 10 November 2014
Multidisciplinary approach to evaluating immunogenicity of biosimilars: lessons learnt and open questions based on 10 years' experience of the European Union regulatory pathway
Chamberlain PD
Biosimilars 2014, 4:23-43
Published Date: 25 June 2014
Production and analysis of a biosimilar erythropoietin in Egypt
Ebied WM, Ahmed HM, Elbarbry FA
Biosimilars 2014, 4:11-22
Published Date: 10 May 2014
Clinical efficacy and safety of Zarzio® (EP2006), a biosimilar recombinant human granulocyte colony-stimulating factor
Tharmarajah S, Mohammed A, Bagalagel A, MacDonald K, Abraham I
Biosimilars 2014, 4:1-9
Published Date: 12 March 2014